About PolpharmaWe are the largest Polish manufacturer of pharmaceuticals and a leader of the Polish pharmaceutical market. We actively operate in the markets of Central and Eastern Europe, the Caucasus and Central Asia.
ResponsibilityBeing the largest Polish pharmaceutical company we want to help people to live a healthy life in a healthy world. Social responsibility is an integral part of the management strategy in our company.
CareerPolpharma's development is possible only thanks to the commitment of our employees as well as the involvement of students and graduates in various business areas.
Strengthening market positionPolpharma, with almost 90 years of history, is one of the largest manufacturers of medicines in Central and Eastern Europe. With the acquisition of Ziołolek, Polpharma plans to expand its product range with unique products, mainly in the dermatological category, which have not previously been produced at its facilities, including the Linomag brand.Linomag is a well-known brand of dermatological products, particularly ointments, which are used to treat various skin problems such as eczema, psoriasis, flare-ups and excessive dry skin. The products contain linseed oil, which lubricates the skin, protects it from water loss and promotes skin regeneration.‘We believe that by combining Polpharma’s commercial potential and Ziołolek’s production and development facilities, we will gain new development opportunities for cosmetics, medical devices and, above all, drugs from the dermatological group (including ointments and creams), which Polpharma does not have at its existing production sites,’ – says Sebastian Szymanek, Polpharma’s CEO.
